We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COOL
251
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
$2.79M 0.08%
+277,365
New +$2.77M
DALS
252
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$2.78M 0.08%
280,900
+115,000
+69% +$1.13M
ATEK
253
DELISTED
Athena Technology Acquisition Corp. II
ATEK
$2.74M 0.08%
+272,216
New +$2.72M
ARYE
254
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$2.71M 0.07%
270,608
WAVC
255
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
$2.7M 0.07%
+269,825
New +$2.67M
JUN
256
DELISTED
Juniper II Corp.
JUN
$2.61M 0.07%
256,189
ZURA icon
257
Zura Bio
ZURA
$552M
$2.59M 0.07%
254,044
RENEU
258
DELISTED
Cartesian Growth Corporation II Unit
RENEU
$2.56M 0.07%
250,000
ICNC
259
DELISTED
Iconic Sports Acquisition Corp.
ICNC
$2.55M 0.07%
+247,801
New +$2.54M
AEAC
260
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$2.54M 0.07%
251,510
EMCG
261
DELISTED
Embrace Change Acquisition Corp
EMCG
$2.53M 0.07%
+246,805
New +$2.5M
PDOT.U
262
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
$2.52M 0.07%
250,000
FSNB.U
263
DELISTED
Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
FSNB.U
$2.51M 0.07%
250,000
ELIQ
264
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$2.48M 0.07%
+245,149
New +$2.45M
AWIN
265
DELISTED
AERWINS Technologies Inc
AWIN
$2.47M 0.07%
2,261
IBER
266
DELISTED
Ibere Pharmaceuticals
IBER
$2.46M 0.07%
+243,944
New +$2.44M
AISP
267
Airship AI Holdings
AISP
$71.3M
$2.46M 0.07%
243,655
+150,000
+160% +$1.5M
KCGI
268
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$2.45M 0.07%
240,388
+40,388
+20% +$408K
ENTF
269
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
$2.39M 0.07%
+232,354
New +$2.36M
CCV
270
DELISTED
Churchill Capital Corp V
CCV
$2.39M 0.07%
240,162
FTEV
271
DELISTED
FinTech Evolution Acquisition Group
FTEV
$2.38M 0.07%
235,616
+160,509
+214% +$1.61M
BRLS icon
272
Borealis Foods
BRLS
$18.1M
$2.37M 0.07%
+229,721
New +$2.35M
ONYX
273
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$2.36M 0.06%
229,407
NVSAU
274
DELISTED
New Vista Acquisition Corp Unit
NVSAU
$2.34M 0.06%
231,716
CXT icon
275
PUT
Crane NXT
CXT
$2.99B
$2.33M 0.06%
66,793

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.